{
}
Barclays has downgraded UniFirst Corporation from Equalweight to Underweight, lowering the price target from $180 to $152, citing poor organic growth and slow strategic progress following the company's fiscal Q2 2025 results. Despite a slight revenue increase to $602.2 million, UniFirst missed earnings expectations, prompting skepticism about its future growth targets. The company recently rejected a takeover offer from Cintas, emphasizing its focus on strategic initiatives and operational improvements.
UBS analyst Joshua Chan has raised the price target for Cintas Corporation to €240, maintaining a Buy recommendation, following the company's strong third-quarter results that exceeded expectations. Cintas reported EPS of €1.13 and sales of €2.61 billion, prompting an increase in its full-year EPS guidance to €4.36-4.40. The company's solid performance and improved organic growth signal resilience and confidence in its growth prospects, despite the recent termination of its acquisition attempt for UniFirst Corporation.
UBS analyst Joshua Chan raised the price target for Cintas shares to $240, maintaining a Buy rating after the company reported a 7.9% reacceleration in organic growth and strong third-quarter results, including an EPS of $1.13. Cintas also increased its annual EPS guidance to $4.36-4.40, reflecting robust operational strength and market confidence. Following these developments, other firms like Truist and Morgan Stanley also adjusted their price targets upward, highlighting Cintas' resilience amid market challenges.
UBS analyst Joshua Chan has raised the price target for Cintas (NASDAQ: CTAS) to $240.00, up from $218.00, while maintaining a Buy rating. This adjustment reflects the firm's positive outlook on the company's performance.
UBS has initiated coverage on Acuren Corp. with a Neutral rating and a price target of $13. Analyst Joshua Chan highlighted the company's potential for mid-single-digit organic growth, contingent on outperforming its market segment, while noting its current return on invested capital is below industry average.Acuren's stock is valued at approximately 10 times the next twelve months' EBITDA, aligning with industry peers. Despite facing profitability challenges, the company maintains strong liquidity, suggesting a balanced risk/reward profile for investors.
UBS has initiated coverage of Acuren Corp with a Neutral rating and a price target of $13. Analyst Joshua Chan highlighted the company's potential for mid-single-digit organic growth, contingent on outperforming its market segment. Acuren, a leader in non-destructive testing and rope access services, currently has a return on investment of 8%, below the industry average, but shows strong liquidity with a current ratio of 3.62. The stock trades at approximately 10 times next twelve months EBITDA, reflecting a balanced risk-reward profile.
UBS has initiated coverage of Acuren Corp (NYSE: TIC) with a Neutral rating and a price target of $13. Analyst Joshua Chan highlighted the company's strong liquidity and mid-single-digit organic growth potential, while noting challenges in profitability and return on invested capital, currently at 8%. Acuren's valuation aligns with industry peers, trading at about 10 times next twelve months EBITDA, suggesting a balanced risk/reward profile for investors.
UBS has lowered its price target for Gartner's stock to $565 from $632 while maintaining a Buy rating, as concerns over business confidence and the impact of DOGE cryptocurrency emerge. Currently trading at $444.50, Gartner's stock has declined 7.6% year-to-date, with analysts projecting a growth rate of 7% for Q1, slightly below previous estimates. Despite these challenges, Gartner reported strong fourth-quarter results, exceeding earnings expectations and generating significant free cash flow, while CEO Gene Hall plans to accelerate hiring for future growth.
UBS has lowered its price target for Gartner shares from $632 to $565 while maintaining a Buy rating, as concerns about business confidence and the impact of DOGE, a cryptocurrency, emerge. Currently trading at $444.50, Gartner's stock is down 7.6% year-to-date, with analysts adjusting revenue growth expectations for the first quarter to the low to mid 7% range.Despite these challenges, Gartner reported strong fourth-quarter results, exceeding earnings expectations with adjusted EPS of $5.45 and revenue of $1.7 billion. The company’s contract value rose 8% year-on-year, and CEO Gene Hall announced plans for accelerated hiring to achieve sustained double-digit growth.
UBS has lowered its price target for Gartner shares to $565 from $632 while maintaining a Buy recommendation, as the stock trades at $444.50, down 7.6% this year. Analysts express concerns over business confidence and potential impacts from DOGE, projecting Q1 revenue growth at 7%, slightly below previous estimates.Despite these challenges, Gartner reported strong fourth-quarter results, with adjusted earnings per share of $5.45 and sales of $1.7 billion, exceeding expectations. The company plans to accelerate hiring to target sustainable double-digit growth moving forward.
Joshua Chan
People
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
barclays downgrades unifirst stock rating and lowers price target to 152
11:09 04.04.2025
ubs raises cintas price target to 240 euros after strong quarterly results
15:19 27.03.2025
ubs raises price target for cintas following strong third quarter results
15:19 27.03.2025
Cintas price target increased to 240 by UBS analyst
14:33 27.03.2025
ubs initiates coverage on acuren with neutral rating and price target
09:35 21.03.2025
ubs initiates coverage of acuren with neutral rating and price target
09:16 21.03.2025
ubs initiates coverage of acuren with neutral rating and price target
09:16 21.03.2025
ubs lowers gartner stock price target amid business concerns and cryptocurrency risks
16:44 19.03.2025
ubs lowers gartner price target amid concerns over business confidence and doge
16:12 19.03.2025
ubs lowers gartner price target amid business confidence concerns and crypto risks
16:12 19.03.2025
Trending
Subcategory
Corporate News
Startups & Entrepreneurship
Economic Indicators
Global Trade Developments
Market Analysis and Predictions
Countries:
Companies:
Currencies:
People: